Skip to main content
OpenTrials

Clinical trial condition

UC (Urothelial Cancer)

Explore clinical trials studying UC (Urothelial Cancer). Study availability and eligibility vary by location and protocol.

9 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

UC (Urothelial Cancer) trial results

Completed

Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

NCT03361865

Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body, UC (Urothelial Cancer)
Locations
  • Arizona Oncology Associates PC- HOPE Tucson, Arizona, United States
  • University of California Irvine Medical Center Orange, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Woodlands Medical Specialists, PA Pensacola, Florida, United States
View all 143 locations
View Trial Details
Completed

Pembrolizumab + Epacadostat vs Pembrolizumab + Placebo in Recurrent or Progressive Metastatic Urothelial Carcinoma

NCT03374488

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • University of California Irvine Medical Center Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • UCLA Hematology Oncology Santa Monica Santa Monica, California, United States
View all 135 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

NCT02872714

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Arizona Oncology Associates (Wilmot) Tucson, Arizona, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Care Center San Francisco, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 96 locations
View Trial Details
Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

NCT02903914

Conditions
Adenocarcinoma, Adenoma, Bladder Cancer, +49 more
Locations
  • University of South Alabama Mobile, Alabama, United States
  • Honor Health/Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Georgetown Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details
Completed

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

NCT02646748

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +59 more
Locations
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • John Wayne Cancer Institute at Providence Saint John's Health Center Santa Monica, California, United States
  • Georgetown University Medical Center Lombardi CCC Washington D.C., District of Columbia, United States
  • Hematology-Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 17 locations
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

NCT05651022

Conditions
Adenocarcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +31 more
Locations
  • University of Southern California- Norris Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions